For patients on the waiting list for a kidney transplant, severe and morbid obesity are associated with a lower chance of receiving an organ, reports a study in the February Journal of the American Society of Nephrology.
A new study confirms that chronic kidney disease (CKD) increases the already-high risk of serious cardiovascular events in diabetic patients with damage to the large blood vessels and suggests that treatment with the anti-diabetic drug pioglitazone may help to lower this risk, reports the January Journal of the American Society of Nephrology.
For patients with dialysis-related anemia, the risk of death is increased when hemoglobin levels remain persistently low over a period several months"”not necessarily when they fluctuate over time, according to a study in the January Clinical Journal of the American Society of Nephrology.
A new indicator of variations in hemoglobin level over time is a strong predictor of the risk of death among patients receiving dialysis for end-stage renal disease (ESRD), reports a study in the December Journal of the American Society of Nephrology.
For older women on dialysis, routine mammograms to screen for breast cancer may not be a cost-effective use of medical resources, according to a paper being presented at the American Society of Nephrology's 40th Annual Meeting and Scientific Exposition in San Francisco.
Why are African-American patients with end-stage renal disease (ESRD) less likely to be placed on waiting lists for kidney transplantation? It's not because they live farther away from transplant centers, reports a study being presented at the American Society of Nephrology's 40th Annual Meeting and Scientific Exposition in San Francisco.
For older patients with end-stage renal disease (ESRD), the results of kidney transplants from "expanded criteria non-beating-heart" donors are not good, according to a paper being presented at the American Society of Nephrology's 40th Annual Meeting and Scientific Exposition in San Francisco.
Nephrologists and other health care providers need to be aware of certain medications and diagnostic test preparations that, in some patients, can cause damage to the kidneys, according to a special clinical update being presented at the American Society of Nephrology's 40th Annual Meeting and Scientific Exposition in San Francisco.
Living kidney donors show no increase in their risk of heart attacks or other cardiovascular events in the years after donation, according to the largest-ever study of the issue, being presented at the American Society of Nephrology's 40th Annual Meeting and Scientific Exposition in San Francisco.
Although estimates have been adjusted downward in light of the most recent data, researchers still predict sharp increases in the U.S. incidence and prevalence of end-stage renal disease (ESRD) in the years ahead, according to a paper being presented at the American Society of Nephrology's 40th Annual Meeting and Scientific Exposition in San Francisco.
Presenting research on the latest issues and scientific breakthroughs in nephrology.
Renal experts will summarize important new research on the topics of cardiovascular risk in chronic kidney disease, consequences of acute kidney injury, racial and ethnic disparities of kidney disease, and anemia management in kidney disease patients, being presented during the American Society of Nephrology's 40th Annual Meeting and Scientific Exposition in San Francisco at a policy-centered news briefing on Saturday, November 3.
For African Americans infected with HIV, the risk of end-stage renal disease (ESRD) is six times higher than for whites with HIV"”and similar to the ESRD risk associated with diabetes, reports a study in the November Journal of the American Society of Nephrology.
A program of education, close medical follow-up, and self-empowerment for patients with end-stage renal disease (ESRD) newly starting dialysis, reduces complications and improves outcomes"”including significant reductions in mortality and hospitalization rates, reports a study in the November Clinical Journal of the American Society of Nephrology.
Recent progress in the prevention and treatment of end-stage renal disease (ESRD) in the United States give reason for "cautious optimism," but skyrocketing costs are a major concern, according to a Special Article in the October Journal of the American Society of Nephrology.
For patients with chronic kidney disease (CKD), the risk of elevated levels of parathyroid hormone (PTH), or hyperparathyroidism"”a significant complication that increases the risk of cardiovascular problems and death"”increases along with body weight, reports a study in the September Clinical Journal of the American Society of Nephrology.
A combination of two types of blood pressure-lowering drugs"”an angiotensin-converting enzyme inhibitor (ACEI) plus an angiotensin-receptor blocker (ARB), added to enzyme replacement therapy (ERT) with agalsidase-beta (Fabrazyme®, Genzyme Corporation, Cambridge, MA)"”is the first treatment shown to stop progressive loss of kidney function in patients with severe kidney involvement due to the rare genetic disorder Fabry disease.
Anemia is one of the most frequent complications of hemodialysis. Treatment with drugs called erythropoiesis-stimulating agents, which stimulate the bone marrow to produce red blood cells, have been a major advance in the treatment of the anemia in chronic kidney disease. However, there is ongoing controversy related to the appropriate clinical use and high costs of ESAs.
Hurricane Katrina and other recent disasters have focused attention on the urgent need for planning to provide health services after natural disasters. Patients with end-stage renal failure pose special challenges, as any large-scale disaster is likely to interrupt the regular dialysis treatments they need to stay alive.
As medical, economic, and policy trends converge to alter the way dialysis care is organized and financed, protecting the unique relationship between dialysis patients and the kidney specialists who direct their care is a top priority, according to a special feature in the July Journal of the American Society of Nephrology.
For young patients with the kidney disease IgA nephropathy (IgAN), early treatment with angiotensin-converting enzyme (ACE) inhibitors can reduce the long-term risk of irreversible kidney damage, suggests a study in the June Journal of the American Society of Nephrology.
Performing high-intensity weight-lifting exercise during dialysis sessions brings meaningful improvements in muscle mass, strength, quality of life, and other important health outcomes in patients with end-stage renal disease (ESRD), reports a study in the May Journal of the American Society of Nephrology.
Approximately ten percent of U.S. adults have a family history of end-stage renal disease (ESRD), and these individuals appear to be at increased risk of developing kidney disease themselves, reports a study in the April Journal of the American Society of Nephrology.
For patients with chronic kidney disease (CKD), the risk of stroke is increased with low blood pressure as well as high blood pressure, reports a study in the March Journal of the American Society of Nephrology.
A "mysterious" condition called nephrogenic systemic fibrosis (NSF)"” which occurs only in patients with advanced kidney disease"”is strongly related to use of gadolinium dyes for MRI scans, reports a study in the March Clinical Journal of the American Society of Nephrology.
Chronic kidney disease is a risk factor for peripheral artery disease (PAD)"”a common but often undetected condition causing reduced blood flow in the legs, reports a study in the February Journal of the American Society of Nephrology.
For patients with type 1 diabetes, obesity is an important risk factor for the development of diabetic kidney disease, reports a study in the January Journal of the American Society of Nephrology.
Living kidney donors who are overweight or obese have increased blood pressure within the remaining kidney"”which could explain the increased long-term risk of kidney damage previously found in this group of donors, reports a paper being presented at the American Society of Nephrology's 39th Annual Meeting and Scientific Exposition in San Diego.
For patients on hemodialysis, the use of dialysis filters coated with vitamin E may provide a simple new approach to the common problem of anemia, reports a paper presented at the American Society of Nephrology's 39th Annual Meeting and Scientific Exposition in San Diego.
Important information will be presented regarding target blood hemoglobin concentrations and clinical outcomes in patients with chronic kidney disease during a session at the American Society of Nephrology's 39th Annual Meeting and Scientific Exposition in San Diego, CA on Saturday, November 18.
For African-Americans with high blood pressure, the combination of risk factors known as metabolic syndrome brings an increased risk of worsening kidney disease, reports a paper being presented at the American Society of Nephrology's 39th Annual Meeting and Scientific Exposition in San Diego.
A standard tool for predicting cardiovascular disease (CVD) risk greatly underestimates the true rate of heart disease among patients receiving dialysis for end-stage renal disease (ESRD), reports a paper being presented at the American Society of Nephrology's 39th Annual Meeting and Scientific Exposition in San Diego.
Dr. Elias Zerhouni, Director of the National Institutes of Health (NIH), and a leader in the field of radiology, will present a State-of-the-Art Lecture entitled "Kidney Disease Research within the NIH Roadmap: Strategies for the Future" during the American Society of Nephrology's 39th Annual Meeting and Scientific Exposition in San Diego, California.
Renowned human geneticist and computational biologist Aravinda Chakravarti, PhD, Director of the McKusick-Nathans Institute and Professor of Medicine at Johns Hopkins University, will present a State-of-the-Art Lecture entitled "Molecular Dissection of Complex Genetic Disease Using the HapMap" during the American Society of Nephrology's 39th Annual Meeting and Scientific Exposition in San Diego, California.
Women who develop high blood pressure (hypertension) during pregnancy have elevated rates of cardiovascular disease (CVD) and kidney disease later in life, reports a paper being presented at the American Society of Nephrology's 39th Annual Meeting and Scientific Exposition in San Diego.
Patients who have undergone gastric bypass surgery for morbid obesity have increased risk factors for the formation of kidney stones, according to a paper being presented at the American Society of Nephrology's 39th Annual Meeting and Scientific Exposition in San Diego.
A simple urine test may enable physicians to help improve their patients' overall diet quality, according to a paper being presented at the American Society of Nephrology's 39th Annual Meeting and Scientific Exposition in San Diego.
The Halpin Foundation and the American Society of Nephrology (ASN) proudly announce the recipient of the Halpin Foundation-ASN Research Grant for 2006, which was created to provide funding for young faculty to foster evolution to an independent research career by providing transition funding toward successful application for an RO1 grant.
Exciting research will be presented at American Society of Nephrology's (ASN) 39th Annual Meeting and Scientific Exposition to be held November 14-19, 2006 in San Diego, California.
Key research on Chronic Kidney Disease (CKD) and Cardiovascular Disease (CVD) will be presented at American Society of Nephrology's (ASN) 39th Annual Meeting and Scientific from November 14-19, 2006 in San Diego, California.
In diabetic patients with hypertension, ACE inhibitors reduce the risk of developing diabetes-related kidney disease, independent of their effect in lowering blood pressure, reports a study in the December Journal of the American Society of Nephrology.
Complimentary registration is available to accredited members of the media to attend Renal Week 2006 from November 14-19 in Philadelphia, PA. Renal Week is the largest international nephrology meeting of its kind and is expected to draw more than 10,000 nephrologists worldwide.
Taking a potassium citrate supplement to counteract the high acidity of the modern diet can lead to increased bone density in older women, suggests a study in the November Journal of the American Society of Nephrology.
Sixty percent of nephrologists don't feel well prepared to make the decision to stop dialysis in kidney disease patients nearing the end of life, reports a study in the November Clinical Journal of the American Society of Nephrology.
Even relatively small reductions in kidney function after radiocontrast dye injection for x-ray procedures can lead to an increased risk of death, reports a study in the October Journal of the American Society of Nephrology.
Medicare beneficiaries with end-stage renal disease (ESRD) are a high-risk group for increased medication costs related to a gap in coverage"”the so-called "doughnut hole," or lack of prescription drug benefits between $2,251 and $5,100 in medication expenses"”in the Medicare Part D prescription drug benefit, suggests a study in the September Journal of the American Society of Nephrology.
Higher birthweights are linked to increased blood pressure in African-American but not white children, reports a study in the September Journal of the American Society of Nephrology.
The higher rate of end-stage renal disease (ESRD) in the United States compared with European countries, such as Norway, reflects a greater risk of worsening kidney disease in the U.S."”not a higher number of people in the early stages of chronic kidney disease (CKD), suggests a study in the August Journal of the American Society of Nephrology.
Studies consistently show an elevated risk of death for people with chronic kidney disease (CKD), with mortality rate rising "exponentially" as the level of kidney function declines, reports a review in the July Journal of the American Society of Nephrology.
Obesity is an important and potentially preventable risk factor for chronic renal failure (CRF), according to a study in the June Journal of the American Society of Nephrology.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right